about
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...
Read More
11.90
0.01
(0.08%)
175.3K
XNAS Volume
XNAS 01 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
GlycoMimetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..